Methemoglobinemia has been reported following topical anesthesia use of benzocaine,particularly with higher concentrations of 14%-20% spray applications applied to the mouth and mucous membrane.An advisory statement informing the public of the association between benzocaine and methemoglobinemia has been released by the Institute of Safe Medication Practices and the U.S.Food and Drug Administration.

Question

Quizplus · Accepted Answer

Both statements are true. Methemoglobinemia is a known risk of using topical benzocaine, especially at higher concentrations, and both the Institute of Safe Medication Practices and the U.S. Food and Drug Administration have issued warnings about this risk.

Methemoglobinemia Has Been Reported Following Topical Anesthesia Use of Benzocaine,particularly